On this episode of the JVRD Author’s Forum podcast, Dr. Ghassan Ghorayeb, Associate Professor and Vice Chair of Clinical Affairs at the West Virginia University Eye Institute, discusses “Supply Chain Volatility of Repackaged Bevacizumab: A Survey of the ASRS,” published in the September/October 2025 issue of the Journal of VitreoRetinal Diseases.Host Dr. Timothy Murray and Dr. Ghorayeb discuss findings from a national ASRS Health Economics Committee survey examining disruptions in the supply of repackaged bevacizumab—the most commonly used anti-VEGF medication in the United States. Hear how recent volatility in access and distribution has affected retina specialists and their patients, how step therapy and payer policies complicate treatment decisions, and what changes may be needed to stabilize supply and safeguard patient care in the years ahead.For more information, visit www.ASRS.org/JVRDForum.Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS), offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief of JVRD, as he discusses cutting-edge developments featured in JVRD with the lead authors, who share clinical pearls and explore their significance in advancing patient care.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related